Related Experiment Video
Updated: Dec 23, 2025

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Furong Liu1, Xin Long1, Bixiang Zhang1
1Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Hubei Province for the Clinical Medicine Research Center of Hepatic Surgery, Wuhan, Hubei, China.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that causes coronavirus disease 2019 (COVID-19) in human beings, has caused a serious public health issue.1 Attention to pancreatic injury is lacking, which may impact patients' prognosis. In this study, we explored the expression and distribution of angiotensin-converting enzyme 2 (ACE2), the receptor of SARS-CoV-2, in the pancreas. Combined with clinical data, we showed that pancreatic injury can occur in some COVID-19 patients.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause pancreatic injury in COVID-19 patients. Researchers explored the virus receptor, angiotensin-converting enzyme 2 (ACE2), in the pancreas to understand this connection.
Area of Science:
- Virology
- Gastroenterology
- Pathology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global health crisis.
- Pancreatic injury in COVID-19 patients is understudied but may affect prognosis.
Purpose of the Study:
- To investigate the expression and distribution of angiotensin-converting enzyme 2 (ACE2) in the pancreas.
- To determine the association between SARS-CoV-2 and pancreatic injury in COVID-19 patients.
Main Methods:
- Exploration of ACE2 expression and distribution within pancreatic tissue.
- Analysis of clinical data from COVID-19 patients.
Main Results:
- ACE2, the SARS-CoV-2 receptor, is present in the pancreas.
- Pancreatic injury was observed in a subset of COVID-19 patients.
Conclusions:
- The pancreas is a potential site for SARS-CoV-2 infection due to ACE2 expression.
- COVID-19 can lead to pancreatic injury, highlighting the need for clinical attention.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin Secretory Vesicles
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

